
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $488.3M | $703.3M | $651.1M | $444.5M | $419M | |
Revenue Growth (YoY) | 16.08% | 44.02% | -7.41% | -31.73% | -5.75% | |
Cost of Revenues | $244.7M | $342.6M | $284.2M | $215.6M | $194.2M | |
Gross Profit | $243.6M | $360.6M | $366.9M | $229M | $224.8M | |
Gross Profit Margin | 49.88% | 51.28% | 56.35% | 51.5% | 53.64% | |
R&D Expenses | $81.7M | $84.9M | $93.9M | $96.1M | $100.8M | |
Selling, General & Admin | $91.4M | $100.6M | $91.5M | $97.8M | $106M | |
Other Inc / (Exp) | $4.8M | $1.1M | $3M | $10.8M | $12.8M | |
Operating Expenses | $173.1M | $185.6M | $186.5M | $193.9M | $206.8M | |
Operating Income | $70.5M | $175.1M | $180.4M | $35.1M | $17.9M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $75.3M | $176.1M | $183.4M | $45.9M | $30.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $4.1M | $11.7M | $12.6M | -$9.8M | -$1.5M | |
Net Income to Company | $71.2M | $164.4M | $170.9M | $55.7M | $32.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $71.2M | $164.4M | $170.9M | $55.7M | $32.2M | |
Basic EPS (Cont. Ops) | $1.19 | $2.73 | $2.96 | $0.97 | $0.57 | |
Diluted EPS (Cont. Ops) | $1.17 | $2.67 | $2.93 | $0.97 | $0.56 | |
Weighted Average Basic Share | $59.7M | $60.3M | $57.8M | $57.2M | $56.8M | |
Weighted Average Diluted Share | $60.8M | $61.5M | $58.4M | $57.6M | $57.1M | |
EBITDA | $98.6M | $210M | $217.8M | $72.4M | $52.5M | |
EBIT | $70.5M | $175.1M | $180.4M | $35.1M | $17.9M | |
Revenue (Reported) | $488.3M | $703.3M | $651.1M | $444.5M | $419M | |
Operating Income (Reported) | $70.5M | $175.1M | $180.4M | $35.1M | $17.9M | |
Operating Income (Adjusted) | $70.5M | $175.1M | $180.4M | $35.1M | $17.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $173.7M | $182.1M | $106.3M | $91.7M | $105.5M | |
Revenue Growth (YoY) | 58.43% | 4.84% | -41.64% | -13.74% | 15.1% | |
Cost of Revenues | $89.3M | $81.5M | $52.3M | $43.9M | $47.3M | |
Gross Profit | $84.4M | $100.7M | $54M | $47.8M | $58.2M | |
Gross Profit Margin | 48.59% | 55.27% | 50.76% | 52.11% | 55.18% | |
R&D Expenses | $20M | $23.7M | $24M | $23.2M | $24.1M | |
Selling, General & Admin | $24.2M | $26M | $24.2M | $24.1M | $27.4M | |
Other Inc / (Exp) | $597K | $554K | $1.7M | $3.5M | $3.2M | |
Operating Expenses | $44.2M | $49.6M | $48.2M | $47.3M | $51.5M | |
Operating Income | $40.2M | $51M | $5.8M | $470K | $6.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $40.8M | $51.6M | $7.5M | $4M | $9.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $985K | $5.4M | $596K | $18K | $1.1M | |
Net Income to Company | $39.8M | $46.2M | $6.9M | $4M | $8.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $39.8M | $46.2M | $6.9M | $4M | $8.8M | |
Basic EPS (Cont. Ops) | $0.66 | $0.78 | $0.12 | $0.07 | $0.15 | |
Diluted EPS (Cont. Ops) | $0.65 | $0.77 | $0.12 | $0.07 | $0.15 | |
Weighted Average Basic Share | $60.2M | $59.2M | $57.1M | $56.8M | $56.9M | |
Weighted Average Diluted Share | $61.5M | $60.1M | $57.6M | $57.1M | $57.1M | |
EBITDA | $48.7M | $60.2M | $15.3M | $9.7M | $14.2M | |
EBIT | $40.2M | $51M | $5.8M | $470K | $6.7M | |
Revenue (Reported) | $173.7M | $182.1M | $106.3M | $91.7M | $105.5M | |
Operating Income (Reported) | $40.2M | $51M | $5.8M | $470K | $6.7M | |
Operating Income (Adjusted) | $40.2M | $51M | $5.8M | $470K | $6.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $552.4M | $711.7M | $575.3M | $429.9M | $432.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $280.9M | $334.8M | $255.1M | $207.2M | $197.6M | |
Gross Profit | $271.5M | $376.9M | $320.2M | $222.8M | $235.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $82.6M | $88.6M | $94.2M | $95.3M | $101.7M | |
Selling, General & Admin | $93.4M | $102.4M | $89.7M | $97.7M | $109.4M | |
Other Inc / (Exp) | $3.6M | $1M | $4.2M | $12.6M | $12.5M | |
Operating Expenses | $175.9M | $191M | $185.1M | $193M | $211M | |
Operating Income | $95.6M | $185.9M | $135.1M | $29.8M | $24.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $99.2M | $187M | $139.3M | $42.4M | $36.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $4.1M | $16.1M | $7.8M | -$10.4M | -$403K | |
Net Income to Company | $95.1M | $170.9M | $131.5M | $52.8M | $37.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $95.1M | $170.9M | $131.5M | $52.8M | $37.1M | |
Basic EPS (Cont. Ops) | $1.59 | $2.85 | $2.29 | $0.92 | $0.65 | |
Diluted EPS (Cont. Ops) | $1.56 | $2.80 | $2.28 | $0.92 | $0.65 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $125.6M | $221.5M | $172.8M | $66.9M | $57M | |
EBIT | $95.6M | $185.9M | $135.1M | $29.8M | $24.2M | |
Revenue (Reported) | $552.4M | $711.7M | $575.3M | $429.9M | $432.8M | |
Operating Income (Reported) | $95.6M | $185.9M | $135.1M | $29.8M | $24.2M | |
Operating Income (Adjusted) | $95.6M | $185.9M | $135.1M | $29.8M | $24.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $173.7M | $182.1M | $106.3M | $91.7M | $105.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $89.3M | $81.5M | $52.3M | $43.9M | $47.3M | |
Gross Profit | $84.4M | $100.7M | $54M | $47.8M | $58.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $20M | $23.7M | $24M | $23.2M | $24.1M | |
Selling, General & Admin | $24.2M | $26M | $24.2M | $24.1M | $27.4M | |
Other Inc / (Exp) | $597K | $554K | $1.7M | $3.5M | $3.2M | |
Operating Expenses | $44.2M | $49.6M | $48.2M | $47.3M | $51.5M | |
Operating Income | $40.2M | $51M | $5.8M | $470K | $6.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | $40.8M | $51.6M | $7.5M | $4M | $9.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $985K | $5.4M | $596K | $18K | $1.1M | |
Net Income to Company | $39.8M | $46.2M | $6.9M | $4M | $8.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $39.8M | $46.2M | $6.9M | $4M | $8.8M | |
Basic EPS (Cont. Ops) | $0.66 | $0.78 | $0.12 | $0.07 | $0.15 | |
Diluted EPS (Cont. Ops) | $0.65 | $0.77 | $0.12 | $0.07 | $0.15 | |
Weighted Average Basic Share | $60.2M | $59.2M | $57.1M | $56.8M | $56.9M | |
Weighted Average Diluted Share | $61.5M | $60.1M | $57.6M | $57.1M | $57.1M | |
EBITDA | $48.7M | $60.2M | $15.3M | $9.7M | $14.2M | |
EBIT | $40.2M | $51M | $5.8M | $470K | $6.7M | |
Revenue (Reported) | $173.7M | $182.1M | $106.3M | $91.7M | $105.5M | |
Operating Income (Reported) | $40.2M | $51M | $5.8M | $470K | $6.7M | |
Operating Income (Adjusted) | $40.2M | $51M | $5.8M | $470K | $6.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $258.9M | $158.1M | $105.4M | $63.9M | $51M | |
Short Term Investments | $190.3M | $372.2M | $248.4M | $247.6M | $249M | |
Accounts Receivable, Net | $35.9M | $41.4M | $20.8M | $14.7M | $27.2M | |
Inventory | $102.9M | $99.3M | $135.4M | $163.2M | $165.6M | |
Prepaid Expenses | $13.3M | -- | -- | -- | -- | |
Other Current Assets | -- | $15.8M | $15M | $22.2M | $21.3M | |
Total Current Assets | $601.2M | $686.8M | $525.1M | $511.6M | $514M | |
Property Plant And Equipment | $166.2M | $179.8M | $176.7M | $164.2M | $149.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $91.8M | $91.8M | $91.8M | $91.8M | $95.3M | |
Other Intangibles | $12.5M | $9M | $6.6M | $4.4M | $8.1M | |
Other Long-Term Assets | $28.2M | $30.6M | $20.9M | $19.5M | $25.4M | |
Total Assets | $903.3M | $1B | $840.1M | $819.9M | $828.8M | |
Accounts Payable | $34.7M | $43.7M | $30.1M | $26.4M | $29.8M | |
Accrued Expenses | $26.9M | $27.4M | $27.4M | $21.5M | $24.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $62.5M | $72.3M | $58.4M | $48.9M | $55.3M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $92.9M | $102.5M | $84.9M | $67.6M | $79.1M | |
Common Stock | $28K | $28K | $24K | $23K | $22K | |
Other Common Equity Adj | -$2.2M | -$3.7M | -$7.3M | -$1.5M | -$3M | |
Common Equity | $810.4M | $912M | $755.2M | $752.2M | $749.8M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $810.4M | $912M | $755.2M | $752.2M | $749.8M | |
Total Liabilities and Equity | $903.3M | $1B | $840.1M | $819.9M | $828.8M | |
Cash and Short Terms | $449.2M | $530.4M | $353.8M | $311.6M | $300M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $343.3M | $170.6M | $94.2M | $56.4M | $49.6M | |
Short Term Investments | $148.1M | $273.4M | $264.4M | $243.2M | $239.7M | |
Accounts Receivable, Net | $42.3M | $30.7M | $20.6M | $12.3M | $22.8M | |
Inventory | $90.5M | $103.1M | $142.4M | $167.9M | $169.1M | |
Prepaid Expenses | $18.2M | $14.7M | -- | -- | -- | |
Other Current Assets | -- | -- | $17.5M | $22.7M | $18.6M | |
Total Current Assets | $642.3M | $592.5M | $539.2M | $502.5M | $499.8M | |
Property Plant And Equipment | $168.7M | $180.1M | $173.5M | $159.9M | $146.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $91.8M | $91.8M | $91.8M | $91.8M | $95.3M | |
Other Intangibles | $11.5M | $8.3M | $6.1M | $3.9M | $7.9M | |
Other Long-Term Assets | $28.5M | $29.1M | $21M | $18M | $25.8M | |
Total Assets | $944.7M | $919.2M | $851.4M | $805.8M | $814.4M | |
Accounts Payable | $38.2M | $36.2M | $34.7M | $27.4M | $33.6M | |
Accrued Expenses | $23.5M | $27.5M | $27.7M | $21.3M | $20.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $62.5M | $69.2M | $63.1M | $49.5M | $55M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $90.9M | $98.6M | $89.1M | $67.6M | $78.6M | |
Common Stock | $29K | $26K | $23K | $22K | $22K | |
Other Common Equity Adj | -$2.8M | -$8.2M | -$5M | -$2.6M | -$2.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $853.8M | $820.6M | $762.3M | $738.2M | $735.8M | |
Total Liabilities and Equity | $944.7M | $919.2M | $851.4M | $805.8M | $814.4M | |
Cash and Short Terms | $491.3M | $444M | $358.6M | $299.6M | $289.3M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $71.2M | $164.4M | $170.9M | $55.7M | $32.2M | |
Depreciation & Amoritzation | $28.1M | $34.9M | $37.3M | $37.4M | $34.6M | |
Stock-Based Compensation | $30.9M | $37.6M | $22.4M | $28.5M | $35.1M | |
Change in Accounts Receivable | -$11.3M | -$5.5M | $19.9M | $6.6M | -$12.3M | |
Change in Inventories | -$12.5M | $3.6M | -$36.2M | -$27.7M | -$2.4M | |
Cash From Operations | $125.6M | $230.9M | $215.3M | $65.8M | $81.2M | |
Capital Expenditures | $70.6M | $47.3M | $39.2M | $20.9M | $17.3M | |
Cash Acquisitions | -- | -- | -- | -- | -$9.5M | |
Cash From Investing | -$28.3M | -$232.8M | $78.3M | -$14.2M | -$25.9M | |
Dividends Paid (Ex Special Dividend) | -$25.1M | -$32.6M | -$41.5M | -$44M | -$46M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$2.6M | -$73.9M | -$311.1M | -$55.3M | -$27.9M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$17.2M | -$98.8M | -$346.4M | -$93M | -$68.2M | |
Beginning Cash (CF) | $178.7M | $258.9M | $158.1M | $105.4M | $63.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $80.2M | -$100.8M | -$52.7M | -$41.4M | -$13M | |
Ending Cash (CF) | $258.9M | $158.1M | $105.4M | $63.9M | $51M | |
Levered Free Cash Flow | $55M | $183.6M | $176.1M | $44.9M | $63.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $39.8M | $46.2M | $6.9M | $4M | $8.8M | |
Depreciation & Amoritzation | $8.5M | $9.1M | $9.5M | $9.3M | $7.5M | |
Stock-Based Compensation | $8.5M | $9M | $7.4M | $6.4M | $8.7M | |
Change in Accounts Receivable | -$6.3M | $10.7M | $705K | $2.2M | $4.7M | |
Change in Inventories | $12.4M | -$3.8M | -$7M | -$4.7M | -$3.5M | |
Cash From Operations | $58.1M | $74.6M | $16.6M | $15.9M | $26.4M | |
Capital Expenditures | $11.1M | $14.7M | $4.1M | $4.3M | $5.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $30.5M | $80.2M | -$18.3M | -$57K | $4.5M | |
Dividends Paid (Ex Special Dividend) | -$7.8M | -$10.7M | -$10.9M | -$11.4M | -$12M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$134.7M | -$1.7M | -$14.6M | -$23.1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$4.2M | -$142.3M | -$9.5M | -$23.3M | -$32.3M | |
Beginning Cash (CF) | $258.9M | $158.1M | $105.4M | $63.9M | $51M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $84.4M | $12.5M | -$11.2M | -$7.5M | -$1.4M | |
Ending Cash (CF) | $343.3M | $170.6M | $94.2M | $56.4M | $49.6M | |
Levered Free Cash Flow | $47.1M | $59.9M | $12.5M | $11.6M | $20.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $95.1M | $170.9M | $131.5M | $52.8M | $37.1M | |
Depreciation & Amoritzation | $30M | $35.6M | $37.7M | $37.1M | $32.8M | |
Stock-Based Compensation | $32.7M | $38.1M | $20.7M | $27.6M | $37.3M | |
Change in Accounts Receivable | -$21.5M | $11.5M | $9.9M | $8.1M | -$9.7M | |
Change in Inventories | $6.1M | -$12.6M | -$39.3M | -$25.4M | -$1.2M | |
Cash From Operations | $157.4M | $247.3M | $157.3M | $65.1M | $91.7M | |
Capital Expenditures | $70M | $50.9M | $28.6M | $21.1M | $18.7M | |
Cash Acquisitions | -- | -- | -- | -- | -$9.5M | |
Cash From Investing | $14.7M | -$183.1M | -$20.2M | $4.1M | -$21.3M | |
Dividends Paid (Ex Special Dividend) | -$27.3M | -$35.4M | -$41.7M | -$44.5M | -$46.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$623K | -$208.6M | -$178.1M | -$68.2M | -$36.3M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$19.3M | -$236.9M | -$213.6M | -$106.9M | -$77.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $152.8M | -$172.6M | -$76.4M | -$37.7M | -$6.8M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $87.3M | $196.4M | $128.7M | $43.9M | $73M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $39.8M | $46.2M | $6.9M | $4M | $8.8M | |
Depreciation & Amoritzation | $8.5M | $9.1M | $9.5M | $9.3M | $7.5M | |
Stock-Based Compensation | $8.5M | $9M | $7.4M | $6.4M | $8.7M | |
Change in Accounts Receivable | -$6.3M | $10.7M | $705K | $2.2M | $4.7M | |
Change in Inventories | $12.4M | -$3.8M | -$7M | -$4.7M | -$3.5M | |
Cash From Operations | $58.1M | $74.6M | $16.6M | $15.9M | $26.4M | |
Capital Expenditures | $11.1M | $14.7M | $4.1M | $4.3M | $5.7M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $30.5M | $80.2M | -$18.3M | -$57K | $4.5M | |
Dividends Paid (Ex Special Dividend) | -$7.8M | -$10.7M | -$10.9M | -$11.4M | -$12M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -$134.7M | -$1.7M | -$14.6M | -$23.1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$4.2M | -$142.3M | -$9.5M | -$23.3M | -$32.3M | |
Beginning Cash (CF) | $258.9M | $158.1M | $105.4M | $63.9M | $51M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $84.4M | $12.5M | -$11.2M | -$7.5M | -$1.4M | |
Ending Cash (CF) | $343.3M | $170.6M | $94.2M | $56.4M | $49.6M | |
Levered Free Cash Flow | $47.1M | $59.9M | $12.5M | $11.6M | $20.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.